Approval · Notice of Compliance 24805 · 2020
MEGESTROL: Notice of Compliance 24805
Issued December 16, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24805
- Date
- December 16, 2020
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Change in product ownership. product name change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MEGESTROL | Not yet assigned | — |
Medicinal ingredients
- MEGESTROL ACETATE 40 MG per TAB
- MEGESTROL ACETATE 160 MG per TAB